2025年2月4日 · EPREX is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic …

EPREX is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).EPREX can reduce the …

2025年1月30日 · Eprex 10000 IU/ml solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

• EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood …

EPREX is prescribed to stimulate your bone marrow to produce more red blood cells. EPREX is used to treat anaemia if you are receiving chemotherapy for solid tumours, malignant …

Symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis for Eprex® pre-filled syringes By intravenous injection, or by subcutaneous injection

Epoetins are authorised for the treatment anaemia in people with chronic renal disease. Four epoetins are authorised in the UK: epoetin alfa (Eprex); darbepoetin alfa (Aranesp); epoetin …

Eprex 3,000units/0.3ml solution for injection pre-filled syringes Janssen-Cilag Ltd

Eprex 10,000units/1ml soln for inj pre-filled syringes: Previous Start Date 08-09-2004 Previous End Date 30-04-2009 Summary. Licensed Route Intravenous, Subcutaneous. Availability …

2014年11月26日 · Evidence-based recommendations on erythropoiesis-stimulating agents (epoetin alfa [Eprex], epoetin beta [NeoRecormon], epoetin theta, epoeitin zeta [Retacrit] and …